Alm. Brand A/S
Alm. Brand A/S – Weekly report on share buybacks
Alm. Brand A/S – Weekly report on share buybacks
Alm. Brand A/S share buy-back program
Transactions during 7 April 2025 – 11 April 2025
On 5 March 2025, Alm. Brand A/S announced a share buy-back program of up to DKK 835.2 million, as described in company announcement no. 21/2025.
The program is carried out in accordance with the Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buy-back program during week number 15:
| Number of shares bought | Average purchase price | Amount (DKK) | |
| Accumulated, last announcement | 5,165,000 | 16.31 | 83,590,050 |
| 7 April 2025 | 400,000 | 14.14 | 5,656,000 |
| 8 April 2025 | 330,000 | 14.67 | 4,841,100 |
| 9 April 2025 | 350,000 | 14.42 | 5,047,000 |
| 10 April 2025 | 300,000 | 15.02 | 4,506,000 |
| 11 April 2025 | 350,000 | 14.40 | 5,040,000 |
| Total, week number 15 | 1,730,000 | 14.50 | 25,090,100 |
| Accumulated under the program | 6,895,000 | 15.99 | 108,680,150 |
With the transactions stated above Alm. Brand A/S holds a total of 100,314,230 own shares corresponding to 6.51 % of the total number of outstanding shares.
Contact
Please direct any questions regarding this announcement to:
Investors and equity analysts:
Head of IR, Rating and ESG reporting
Mads Thinggaard
Mobile no. +45 2025 5469
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom